| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |